The Glaxo and Techne-backed biopharmaceutical firm dropped its price to $10 and issued an extra 500,000 shares prior to its flotation yesterday.

The online video platform developer, backed by a host of corporate investors, will price its shares at between $10 and $12 when it floats.

The waste conversion company is preparing a $125m initial public offering, with backers including Waste Management of Canada seeking a return on their investment.

The Fidelity-backed cancer drug developer has postponed its $191m IPO after setting the range, according to reports.

The computer security firm has raised $128m upon its flotation on NASDAQ, with Intel Capital garnering nearly $12m from the offering.

The internet services company will be floating at between $10 and $12 a share, with Intel Capital among the backers looking to cash in.

Facebook advertises its returns to corporations,

FXall, the electronic trading platform formerly known as FX Alliance, which is backed by a range of financial services firms, will offer its shares at between $13.50 and $15.50 when it floats.